|
EMA: Biosimilars Applications Can Reference Non-EU Products
The European Medicines Agency (EMA) will soon allow biosimilars sponsors to reference biologics made outside the European Economic Area (EEA) in some preclinical and clinical studies required for approval.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives